← Eichor
Condition: Stimulant Use Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stimulant Use Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Accelerated rTMS for Substance Use Disorder and Depression
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06424184
Neuromodulation and Cognitive Training for Substance Use Disorders
NA · 1 location(s) · University of Minnesota · NCT04426214
HIV, Equity, and Addiction Training (HEAT) Program
NA · 1 location(s) · University of Alabama at Birmingham · NCT06370481
Psilocybin for Methamphetamine Addiction
EARLY_Phase 1 · 1 location(s) · Kevin Murnane · NCT06899594
Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07673380
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
NA · 1 location(s) · Stanford University · NCT06578429
Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treat
Phase 2 · 1 location(s) · Washington State University · NCT06323837
Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
Phase 1 · 1 location(s) · University of Minnesota · NCT06790576
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
NA · 1 location(s) · University of Rochester · NCT05943171
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
NA · 2 location(s) · University of Texas Southwestern Medical Center · NCT07136363
Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06788587
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
NA · 1 location(s) · Michele Staton · NCT07179614
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
NA · 4 location(s) · Elana Rosenthal · NCT06513156
Testing Implementation Strategies to Scale-up a Multicomponent Continuum of Service Intervention for Families Involved i
NA · 1 location(s) · Chestnut Health Systems · NCT07365293
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
NA · 1 location(s) · University of Miami · NCT05958017
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
NA · 1 location(s) · Oregon Health and Science University · NCT06461962
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
NA · 9 location(s) · Northwestern University · NCT05702021
Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
Phase 2 · 4 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05854667
Smartphone Services for Stimulant Use Disorder
NA · 1 location(s) · DynamiCare Health · NCT07092059
Optimizing Pregnancy and Treatment Interventions for Moms 3.0
NA · 1 location(s) · University of Utah · NCT07586917
Project neuroARTEMIS
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06814275
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06444256
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.